argus

MPS Limited

NSE: MPSLTDINE943D010174,435 Cr

Timeline

Time (IST)TypeMEventSrc
07 Feb, 03:33 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
07 Feb, 03:31 pmMPS Limited has informed the Exchange about Transcriptnse
04 Feb, 10:25 pmMPS Limited has informed the Exchange about Funding arrangements for the proposed acquisition of Unbound Medicine, Inc., by MPS North America LLC, a wholly-owned subsidiary of MPS Limited.nse
03 Feb, 07:04 pmSubmission of Newspaper Publication of Un-Audited Financial Results for the Third Quarter (Q3) & Nine Months ended 31 December 2025nse
02 Feb, 08:34 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
02 Feb, 08:32 pmAudio Recording for the Earnings Conference Call inter-alia on Un-Audited Financial Results of MPS Limited for the Third Quarter (Q3) & Nine Months ended 31 December 2025.nse
02 Feb, 08:14 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Resignation of Directorbse
02 Feb, 08:12 pmMPS Limited has informed the Exchange regarding Resignation of Ms Yamini Tandon as Non- Executive Director of the company w.e.f. close of business hours on February 02, 2026.nse
02 Feb, 06:56 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015bse
02 Feb, 06:55 pmMPS Limited has informed the Exchange regarding 'Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015'.nse
02 Feb, 04:19 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
02 Feb, 04:17 pmMPS Limited has informed the Exchange about Investor Presentationnse
02 Feb, 04:03 pmMPS Ltd - 532440 - Un-Audited Financial Results For The Third Quarter (Q3) & Nine Months Ended 31 December 2025bse
02 Feb, 04:01 pmMPS Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
02 Feb, 03:56 pmMPS Ltd - 532440 - Board Meeting Outcome for Un-Audited Financial Results For The Third Quarter (Q3) And Nine Month Ended 31 December 2025bse
31 Jan, 12:02 amPress Release- MPS North America LLC Acquires 100% stake in Unbound Medicine, Inc., USA.nse
30 Jan, 11:59 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
30 Jan, 11:56 pmAcquisition of Unbound Medicine, Inc., USA, by MPS North America LLC, a wholly owned subsidiary of the Company.nse
30 Jan, 11:53 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Acquisitionbse
28 Jan, 08:23 pmSchedule of Earnings Conference Call on Un-Audited Financial Results of MPS Limited for the Third Quarter (Q3) & Nine Months ended 31 December 2025.nse
22 Jan, 05:57 pmMPS Ltd - 532440 - Board Meeting Intimation for Consideration And Approval For The Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter (Q3) And Nine Month Ended 31 December 2025.bse
12 Jan, 12:19 pmMPS Ltd - 532440 - Clarification sought from MPS Ltdbse
09 Jan, 09:19 pmSignificant increase in volume has been observed in MPS Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. MPS Limited has submitted their response.nse
09 Jan, 06:30 pmSignificant increase in volume has been observed in MPS Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse
29 Dec, 03:33 pmIntimation for the Appointment of Mrs. Papinani Radha Rani as the General Counsel and Senior Management Personnel of the Company, effective from 29 December 2025.nse
29 Dec, 03:27 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Change in Managementbse
24 Dec, 05:46 pmIntimation regarding Re-Appointment of Mr. Suhas Khullar as an Independent Non-Executive Director of the Company for a second term of five consecutive years, w.e.f. 01 January 2026 to 31 December 2030, subject to shareholders approval.nse
24 Dec, 05:37 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Change in Managementbse
24 Dec, 05:25 pmIntimation under Regulation 30 of SEBI (LODR) Regulations, 2015 Re-Appointment of Independent Director and Shifting of Registered Office of the Company.nse
22 Dec, 05:10 pmWe wish to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company, at its meeting held today, 22 December 2025, has considered and approved the Grant of 28,906 Options under the "MPS Limited- Employee Stock Options Scheme 2023"nse
15 Dec, 03:44 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Change in Managementbse
15 Dec, 03:37 pmMPS Limited has informed the Exchange regarding Resignation of Mrs Geetika Hans as Other of the company w.e.f. December 15, 2025.nse
19 Nov, 10:21 pmTranscript of the Earnings Conference Call inter-alia on the Un-Audited Financial Results of the Company for the Second Quarter (Q2) and Half Year (H1) ended 30 September 2025.nse
19 Nov, 10:13 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
12 Nov, 07:43 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
12 Nov, 07:12 pmMPS Limited has informed the Exchange about Audio Recording for the Earnings Conference Call inter-alia on Un-Audited Financial Results of MPS Limited for the Second Quarter (Q2) and Half Year (H1) ended 30 September 2025nse
12 Nov, 11:13 amMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
12 Nov, 11:08 amMPS Limited has informed the Exchange about Investor Presentationnse
12 Nov, 10:46 amMPS Ltd - 532440 - Un-Audited Financial Results For The Second Quarter (Q2) And Half Year (H1) Ended 30 September 2025bse
12 Nov, 10:38 amMPS Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
12 Nov, 10:36 amMPS Ltd - 532440 - Board Meeting Outcome for Un-Audited Financial Results For The Second Quarter (Q2) And Half Year (H1) Ended 30 September 2025bse
07 Nov, 04:32 pmSchedule of Earnings Conference Call on Un-Audited Financial Results of MPS Limited for the Second Quarter (Q2) and Half Year (H1) ended 30 September 2025.nse
04 Nov, 04:50 pmMPS Ltd - 532440 - Board Meeting Intimation for Consideration And Approval For The Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Second Quarter (Q2) And Half Year (H1) Ended 30 September 2025.bse
28 Oct, 06:57 pmMPS Limited has informed the Exchange regarding a press release dated October 28, 2025, titled "MPS Interactive Systems Limited Completes 100% Acquisition of the Liberate Group.".nse
28 Oct, 06:53 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
28 Oct, 06:50 pmMPS Interactive Systems Limited acquired the remaining stake in Liberate Learning Pty Ltd and App-eLearn Pty Ltd, increasing its shareholding from 82.50% to 100%, and in Liberate eLearning Pty Ltd, increasing its shareholding from 65% to 100%.nse
28 Oct, 06:43 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Acquisitionbse
17 Oct, 09:43 pmMPS Limited has informed the Exchange regarding a press release dated October 17, 2025, titled "MPS Interactive Systems Limited Acquires Additional Stake in Liberate Group.".nse
17 Oct, 09:37 pmMPS Ltd - 532440 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
17 Oct, 09:29 pmMPS Interactive Systems Limited acquired an additional stake in Liberate Learning Pty Ltd and App-eLearn Pty Ltd, increasing its shareholding from 65.00% to 82.50% .nse